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Seven Sm proteins, termed B/B, D1, D2, D3, E, F, cytosolic extract by size exclusion chromatography and
incubated individual fractions with recombinant GST-and G, assemble in an ordered manner onto U
D3-tail (containing the RG-dipeptide motif of D3) in thesnRNAs to form the Sm core of the spliceosomal
presence of [3H]S-adenosylmethionine (SAM). ProteinsnRNPs U1, U2, U4/U6, and U5 [1–4]. The survival
methylation was subsequently analyzed by SDS-PAGEof motor neuron (SMN) protein binds to Sm proteins
and fluorography. As shown in Figure 1a, the GST-D3-and mediates in the context of a macromolecular
tail was efficientlymethylated in a peak that corresponded(SMN-) complex the assembly of the Sm core [5–9].
to a molecular mass of roughly 500 kDa (lanes 5 throughBinding of SMN to Sm proteins is enhanced by
9), whereas GST alone was not modified (data not shown).modification of specific arginine residues in the Sm
To test whether full-length Sm proteins were alsomethyl-proteins D1 and D3 to symmetrical
ated, we incubated the peak fraction with recombinantdimethylarginines (sDMAs), suggesting that
heterooligomeric complexes composed of Sm proteinsassembly might be regulated at the
D1/D2, B(1-168)/D3, and E/F/G and assayed for methyl-posttranslational level [10–12]. Here we provide
transferase activity as described above (Figure 1b). Noteevidence that the previously described pICln-
that, due to their generation in E. coli, none of the recom-complex [13], consisting of Sm proteins, the
binant Sm proteins contained sDMA residues. As shownmethyltransferase PRMT5, pICln, and two novel
in Figure 1b, the RG-containing Sm proteins (i.e., D1factors, catalyzes the sDMA modification of Sm
and D3, lanes 1 and 2) but not the Sm proteins that eitherproteins. In vitro studies further revealed that the
contain a shortened RG tail [i.e., B(1-168); lane 1] or lackpICln complex inhibits the spontaneous assembly of
an RG-tail (i.e., D2, E, F, and G; lanes 1 through 3) wereSm proteins onto a U snRNA. This effect is
efficientlymodified. Importantly, methylation in the peakmediated by pICln via its binding to the Sm fold of
fractions was specific for Sm proteins, as neither GST norSm proteins, thereby preventing specific
histone 2A (an often-used model substrate for methyl-
interactions between Sm proteins required for the transferases [14]) were modified (lanes 5 and 6). To ana-
formation of the Sm core. Our data suggest that lyze whether the Sm proteins received a symmetrical (s)
the pICln complex regulates an early step in the or asymmetrical (a) DMAmodification, we took advantage
assembly of U snRNPs, possibly the transfer of Sm of the previous observation that only sDMA-modified Sm
proteins to the SMN-complex. proteins can bind to SMN [10]. Thus, endogenous SMN
should copurify with an Sm protein subsequent to incu-Addresses: *Max-Planck Institute of Biochemistry, Am Klopferspitz
bation in a cellular extract only if the critical arginine18a, D-82152 Martinsried, Germany. † Max-Planck Institute of
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Germany. ‡ Paul Scherrer Institute, Life Sciences OSRA/007, CH- GST-D3-tail was incubated with cytosolic extract to allow
5232 Villigen PSI, Switzerland. methylation in vitro (Figure 1c, lane 1, upper panel). The
GST-D3-tail protein was subsequently isolated with glu-Correspondence: Utz Fischer
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SMNwas monitored byWestern blotting using anti-SMN
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S-adenosylhomocysteine (SAH) prevented the interaction
Current Biology 2001, 11:1990–1994 between SMN and GST-D3-tail (lane 2, compare upper
and lower panel). Similar results were obtained with other
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Sm proteins (data not shown). Taken together, these data 2001 Elsevier Science Ltd. All rights reserved.
show that HeLa cytosol contains a methyltransferase ac-
tivity that specifically introduces sDMA residues into the
RG-rich tails of Sm proteins.
Results and discussion
Identification of a sDMA-modifying activity for Sm The pICln complex catalyzes the formation
proteins in HeLa cytosol of sDMAs in Sm proteins
To identify the factor(s) that catalyze the formation of pICln has previously been shown to be associated with
Sm proteins and the type II (sDMA-generating) argininesDMAs in Sm proteins, we initially fractionated HeLa
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Figure 1 Figure 2
A macromolecular complex catalyzes the sDMA modification of SmD1
and SmD3. (a) HeLa cytosolic extract was fractionated by size
Affinity-purified pICln-complex catalyzes the formation of sDMAs inexclusion chromatography. To monitor methyltransferase activity, each
Sm proteins. (a) Protein elution profile of an anti-pICln affinity columnfraction was incubated with recombinant GST-D3-tail in the presence
(lane 3) and an anti-GST control column (lane 2). Proteins wereof [3 H]-SAM, separated by SDS-PAGE, and analyzed by fluorography.
separated by SDS-PAGE alongside a protein marker (lane 1) andPositions of size marker proteins are given at the top of the gel. (b)
affinity-purified UsnRNP proteins (lane 4) and were visualized by silverThe peak fraction (fraction 7) of the experiment shown in (a) was
staining. Specific proteins of the pICln elution are indicated. Theincubated with either SmB(1-168)/D3 (lane 1), SmD1/D2 (lane 2),
band indicated by * is a degradation product of plCln. (b) Anti-pIClnSmE/F/G (lane 3), GST-SmD3-tail (lane 4), GST-tag (lane 5), or
antibodies and anti-GST antibodies were coupled to protein Ghistone H2A (lane 6) in the presence of [3 H]-SAM. The modified
Sepharose beads and incubated with HeLa cytosolic extract. Theproteins were analyzed as in (a). (c) sDMA modification of GST-SmD3-
immunoprecipitates (lanes 1 and 2) and the correspondingtail in cytosolic extract. GST-SmD3-tail was incubated with cytosolic
supernatants (lanes 3 and 4) were assayed for methyltransferaseextract, [3 H]-SAM and either water (lane 1) or SAH (lane 2). After
activity, using SmD1/D2 complex as substrate. The methylationincubation at 37C, GST-SmD3-tail was isolated by binding to
assays shown in lanes 5 and 6 were preincubated with affinity-purifiedglutathione Sepharose beads. Coisolated SMN was detected by
anti-GST antibodies or anti-PRMT5 antibodies, respectively. (c)Western blotting with anti-SMN monoclonal antibody 7B10 (lower
Quantification of the antibody inhibition shown in Figure 2b, lanes 5panel), and GST-D3-tail methylation was analyzed by fluorography
and 6.(upper panel).
N-methyltransferase PRMT5 [13, 15, 16]. It was therefore identify the 200 kDa component have not yet been ob-
tempting to speculate that this complex accounted for tained.
the methyltransferase activity observed in our assay (see
Figure 1). To test for this possibility, we initially isolated
the pICln complex by anti-pICln immunoaffinity chroma- Next, the pICln complex was purified as described above
and tested for methyltransferase activity. As shown intography and identified the proteins by MALDI-TOF
and Western blotting. Consistent with previous reports Figure 2b, SmD1 was strongly modified by the affinity-
purified pICln complex (lane 1), whereas the flow through[13], this complex contains pICln, PRMT5, and all Sm
proteins (i.e., B/B, D1, D2, D3, E, F, and G; Figure 2a, of the columnwas inactive (lane 4). In contrast, nomethyl-
ation of SmD1 could be detected in a control purificationlane 3). In addition, two proteins with apparent molecular
masses of 45 kDa and 200 kDa also coeluted specifically using a nonrelated antibody (lanes 2 and 3). In the view of
these data, we conclude that the pICln complex generatesfrom the column. The 45 kDa component (termed
“WD45”) was identified as a WD motif protein of un- sDMA residues in Sm proteins. Importantly, antibodies
directed against PRMT5 reduced significantly the meth-known function that shares pronounced similarity with
-transducin (see the Supplementary material available ylation activity of the pICln complex (Figure 2b,c). This
observation together with the previous finding that iso-with this article online). This protein is likely to be identi-
cal to a factor termed “IBP42,” which had previously lated PRMT5 catalyzes the formation of sDMA in a vari-
ety of substrates in vitro suggests that PRMT5 is thebeen identified [13]. Peptide masses that unequivocally
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Figure 3
Isolated pICln complex that lacks Sm proteins
inhibits U snRNP assembly in vitro. (a) HeLa
cytosolic extract prepared under low salt
conditions was passed over an anti-pICln
column (lane 4) or an anti-GST control column
(lane 2). Eluted proteins from both columns
were resolved by SDS-PAGE lane by lane with
a U snRNP protein marker (lane 3) and a
molecular weight marker (lane 1). All indicated
proteins except for p200 were identified by
MALDI-TOF. (b) 32P-labeled U1 snRNA was
incubated with either TPs (lane 2) or TPs
supplemented with anti-Sm antibody Y12
(lane 3), purified pICln(Sm) complex (lane
4), a control eluate of an anti-GST column
(lane 5), or recombinant GST-pICln either
prior to (lane 7) or after (lane 8; indicated with
p  post) the assembly reaction. Lanes 1,
6, and 9 show the U1 snRNA in the absence
of TPs. Complex formation was analyzed by
native gel electrophoresis.
catalytic component of the pICln complex that generates compare lanes 4 and 5). In contrast, binding of the U1
snRNP-specific protein A was not affected (lanes 4 andsDMA in Sm proteins in vivo.
5). Next, we tested whether the observed inhibition of
assembly could be attributed to pICln alone, as a previousThe pICln complex inhibits assembly of U snRNPs in vitro
study had suggested [13]. Indeed, when snRNP proteinsby binding to the Sm domain of Sm proteins
were preincubated with recombinant pICln, formation ofWe next tested whether the pICln complex fulfills, apart
complex M was abolished (Figure 3b, compare lane 7from its methyltransferase activity, an additional role in
with lanes 2 and 5). Importantly, an inhibition of assemblythe biogenesis of U snRNPs as suggested previously [13].
was strongly dependent on preincubation of pICln withFor this purpose, native U snRNP proteins, including
Sm proteins, and no effect was observed when pICln wasall sDMA-modified Sm proteins (termed “TPs”), were
added after the reconstitution reaction had been com-prepared from affinity-purified nuclear U snRNPs and
pleted (compare lanes 7 and 8). Thus, pICln is more likelyincubated with in vitro transcribed and 32P-labeled U1
to prevent binding of Sm proteins onto U snRNA thansnRNA. U snRNP complex formation was subsequently
to disassemble the formed U snRNP.analyzed by native gel electrophoresis. In agreement with
previous findings, the U1 snRNA was shifted to two com-
plexes, termed “R1” and “M” (Figure 3b, lane 2). Anti- To analyze the underlying mechanism of pICln’s func-
tion, we tested whether pICln binds directly to Sm pro-Sm antibodies supershifted complex M (lane 3), indicat-
ing that it contains the Sm core assembled on U1 snRNA. teins and which domains are involved. Recombinant
GST-pICln was immobilized on glutathione SepharoseComplex R1 does not contain Sm proteins and corre-
sponds to U1 snRNA bound to the U1A protein (lane beads and subsequently incubated with the bacteri-
ally expressed and hence unmethylated Sm complexes3, see also [9] for a detailed characterization of these
complexes). To test whether the pICln complex can inter- D1/D2, E/F/G, and B(1-168)/D3. As shown in Figure 4a,
each Sm complex bound efficiently to pICln, whereasfere with U snRNP assembly, we isolated a pICln-con-
taining complex under conditions that allowed for the only marginal binding to GST was observed (compare
lanes 8 through 10 with 14 through 16). None of the Smcoisolation of all previously described components except
for the Sm proteins (i.e., pICln, PMRT5, WD45, and complexes bound to a significant amount to the GST-
SMN1-160 fragment, confirming that this interaction isp200; Figure 3a, lane 4). The pICln(Sm) complex was
then incubated with TPs, and assembly was analyzed as enhanced upon sDMAmodification of Sm proteins (lanes
11 through 13) [10]. In contrast, sDMA-modified Sm pro-described above. Strikingly, when this complexwas added
to an assembly reaction, the formation of the U1 snRNP teins obtained from isolated HeLa-U snRNPs bound
equally well to pICln and SMN (Figure 4b, compare laneswas severely impaired as compared to a control reconstitu-
tion lacking purified pICln(Sm) complex (Figure 3b, 2 and 3). These results show that pICln interacts directly
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Figure 4 the tail domain and hence consists of the Sm domain only
bound efficiently to immobilized GST-pICln (Figure 4c,
lane 7). In control reactions, no interaction of this mutant
was observed with GST-SMN1-160 (which requires the
sDMA-modified tails for interaction) or GST alone (lanes
1 and 4). Moreover, a double point mutation within the
Sm domain (L58 was substituted with K, and I60 was
substituted with R) abolished binding of SmD1 to pICln
but not to SMD3 (compare lanes 3, 6, and 9). Similar
results were obtained with SmB (data not shown). These
observations provide strong support for a direct binding
of pICln onto the Sm domain of Sm proteins (see Figure
4d for a model). Moreover, the mode of interaction be-
tween both proteins implies that pICln inhibits UsnRNP
assembly by preventing contacts among Sm proteins re-
quired for the formation of the heptameric ring in the Sm
core.
Friesen et al. [10] have recently reported that the presence
of symmetrical dimethylarginines (sDMAs) in the Sm pro-
teins D1 and D3 is a prerequisite for binding of these
proteins to SMN and hence for the assembly onto U
snRNA. Here we have shown that the macromolecular
pICln complex mediates the formation of sDMAs in
SmD1 and SmD3. Consistently, this complex contains
as the catalytic subunit the type II methyltransferase
PRMT5 [14]. It is interesting to note that isolated PRMT5
methylates a variety of different proteins, including Sm
proteins, histones, myelin basic protein, and fibrillarin
[14]. In striking contrast, the 500 kDa pICln complexpICln binds directly to the Sm domain of Sm proteins. (a) Recombinant
GST-pICln (lanes 8 through 10), GST-SMN1-160 (lanes 11 through efficiently modifies Sm proteins but not histones or GST
13), and GST (lanes 14 through 16) were immobilized on glutathione in the same assay. Hence, it is likely that PRMT5-inter-
Sepharose beads and incubated with recombinant heterooligomeric acting factors such as pICln, WD45, and/or p200 conferSm complexes B(1-168)/D3 (lane 8, 11, and 14), D1/D2 (lane 9, 12,
substrate specificity toward Sm proteins in vivo.and 15), and E/F/G (lane 10, 13, and 16). Bound proteins were
eluted with protein sample buffer, resolved by SDS-PAGE, and
visualized by Coomassie staining. Lanes 2 through 7 show the
The earlier observation that the PRMT5-interacting pro-proteins used for the binding studies; lanes 1 and 17, protein size
markers. (b) GST-pICln (lane 2), GST-SMN1-160 (lane 3), and GST tein pICln interfered with the assembly of the Sm core
(lane 4) were immobilized on glutathione Sepharose beads and when injected into Xenopus laevis oocytes lead to the pro-
incubated with TPs obtained from affinity-purified U snRNPs. Lane
posal that pIClnmight act as a negative regulator of assem-1 shows the TPs used for the binding reaction. Proteins were separated
bly [13]. In support of this notion, we have shown thatby SDS-PAGE and visualized by silver staining. (c) GST-pICln (lanes
7 through 9), GST-SMN1-160 (lanes 1 through 3), and GST (lanes pICln as part of a multiprotein complex directly interacts
4 through 6) were immobilized on glutathione Sepharose beads and with Smproteins and inhibits the assembly ontoU snRNA
incubated with in vitro translated and 35S-labeled D1tail (lanes 1, 4,
in an in vitro reconstitution assay. Importantly, pIClnand 7), D1 (lanes 2, 5, and 8), and D1(M58/60) (lanes 3, 6, and
binds to the Sm domain, i.e., the common structure found9). Bound proteins were analyzed by SDS-PAGE and fluorography.
(d) A schematic representation of the data shown in Figure 4a–c. in all Sm proteins. As Sm proteins interact via this Sm
domain to form the heptameric ring of the Sm core, it is
likely that pICln inhibits assembly by preventing the
formation of specific contacts among Sm proteins.
with Sm proteins but, unlike SMN, does not require the
presence of sDMAs for binding.
Our data are consistent with a dual function of the pICln
complex at an early stage of U snRNP assembly. WeThe binding of pICln to all Sm heterooligomeric com-
plexes suggested that this interaction involves the Sm propose that newly synthesized Sm proteins initially bind
to the pICln complex where B/B, D1, and D3 receivedomain, i.e., the N-terminal sequence that is common to
Sm proteins and required for the formation of the Sm the sDMA-modification. The pICln complex may then
control the transfer of the Sm proteins onto the SMNcore. Indeed, a radiolabeled SmD1 translate that lacks
1994 Current Biology Vol 11 No 24
complex to allow their subsequent assembly onto a U
snRNA.
Supplementary material
Supplementary material including materials and methods and the amino
acid sequence of a novel WD domain-containing protein is available at
http://images.cellpress.com/supmat/supmatin.htm.
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